-
Commitment to our readers
18 years
Helping you save money
Reviewed
by experts
Cited by
major publications
Finder maintains full editorial independence to ensure for our readers a fair assessment of the products, brands, and services we write about. That independence helps us maintain our reader's trust, which is what keeps you coming back to our site. We uphold a rigorous editorial process that ensures what we write and publish is fair, accurate, and trustworthy — and not influenced by how we make money.
We're committed to empowering our readers to make sound and often unfamiliar financial decisions.
We break down and digest information information about a topic, product, brand or service to help our readers find what they're looking for — whether that's saving money, getting better rewards or simply learning something new — and cover any questions you might not have even thought of yet. We do this by leading with empathy, leaning on plain and conversational language that speaks directly, without speaking down.
What are mental health stocks?
When you buy mental health stocks, you’re buying shares in publicly traded companies that deliver products or services related to the mental health industry. This includes creating treatments or medications, offering counselling services, producing educational materials and developing technology to assist mental healthcare professionals and clients.
How to invest in therapy stocks
- Research stocks. You can check out a list of mental health stocks to watch below. Compare stock prices, past performance and company financials to decide which stocks are right for you.
- Choose an investment platform. Look at fees, features and whether you can get access to the exchanges on which your stocks are trading.
- Open an account and add funds. You might need to wait for your account to be verified and for your funds to hit the account before you can begin.
- Find your chosen stock. Search for stocks by name (Pfizer Inc.) or ticker symbol (PFE).
- Submit your order, review and buy. Buy stocks with a market order. Some platforms lets you buy fractional shares or place limit orders that trigger a buy or sell when a stock reaches your desired price.
Mental health stocks to watch
Teladoc Health, Inc. (TDOC)
Teladoc Health provides virtual healthcare services in the United States and internationally. Through the Teladoc, Livongo, and BetterHelp brands, it offers services for a wide range of conditions including diabetes, chronic kidney disease, cancer, congestive heart failure and mental health conditions.
- Healthcare
- Exchange: NYSE
- Dividend yield: N/A
- Price-earnings (P/E) ratio: N/A
Eli Lilly and Company (LLY)
Eli Lilly and Company discovers, develops and markets human pharmaceuticals worldwide. Its portfolio of products include treatments for depression, anxiety, schizophrenia, bipolar disorder, diabetes, cancer, arthritis, osteoporosis and other conditions. The company makes Prozac (fluoxetine), one of the most widely used FDA-approved antidepressants on the market.
- Healthcare
- Exchange: NYSE
- Dividend yield: 1.21%
- Price-earnings (P/E) ratio: 46.63
Pfizer Inc. (PFE)
Pfizer discovers, develops, manufactures, markets, distributes and sells a wide range of biopharmaceutical products worldwide. The company makes a number of widely used medications that treat mental health conditions including Xanax (alprazolam), Effexor (venlafaxine) and Zoloft (sertraline).
- Healthcare
- Exchange: NYSE
- Dividend yield: 3.16%
- Price-earnings (P/E) ratio: 9.63
Talkspace, Inc. (TALK)
Talkspace is a New York based virtual behavior healthcare company that delivers healthcare services through encrypted web and mobile platform. The company offers treatment options for psychiatry therapy as well as adolescent, individual and couples therapy.
- Healthcare
- Exchange: Nasdaq Global Select Market
- Dividend yield: N/A
- Price-earnings (P/E) ratio: N/A
Bristol-Myers Squibb Company (BMY)
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures and markets biopharmaceutical products worldwide including Abilify (Aripiprazole), an antipsychotic medication. It offers products for neuroscience, hematology, oncology, cardiovascular, immunology, fibrotic and covid-19 diseases.
- Healthcare
- Exchange: NYSE
- Dividend yield: 2.95%
- Price-earnings (P/E) ratio: 24.25
Johnson & Johnson (NYSE: JNJ)
Johnson & Johnson makes and sells healthcare products worldwide. Its brands include Johnson’s, Aveeno, Listerine, Neutrogena, Tylenol and Band-Aid. Its subsidiary, Janssen Pharmaceuticals, develops a number of treatments for mood disorders, neurodegenerative disorders and schizophrenia including Haldol (haloperidol), Risperdal (risperidone) and Invega (paliperidone).
- Healthcare
- Exchange: NYSE
- Dividend yield: 2.70%
- Price-earnings (P/E) ratio: 24.75
Overview of mental health disorders in the US
Around 1 in 5 adults in the US have a mental health disorder, according to 2020 data released by the Substance Abuse and Mental Health Services Administration (SAMHSA). This is roughly 52.9 million people or 21% of the US adult population.
The data shows a higher rate of mental health disorders among females (25.8%) than males (15.8%). There was also a higher rate of mental health illness among young adults aged 18-25 (30.6%) than adults aged 26-49 (25.3%) or 50+ (14.5%).
Many conditions fall under the umbrella of mental health disorders including anxiety disorder, panic disorder, bipolar disorder, eating disorder, borderline personality disorder, depression, obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), schizophrenia and trauma.
Mental health problems aren’t new, but they’re certainly starting to get more awareness, with several celebrities, including Ryan Reynolds, Beyoncé, and even Prince Harry coming out to talk about their own mental health. Increasing awareness may help convince people to seek help for their problems, thereby driving up demand for mental health services.
What are the risks of investing in mental health stocks?
One of the main risks of investing in mental health stocks is that companies you don’t invest in will be quicker to come out with new treatments or technologies. For therapy stocks in companies that offer program-based treatments, there’s a risk that programs will become ineffective or that users will lose interest.
Check out Finder's picks for the best brokerage accounts
Compare top brokerage accounts and apps to help you maximize your investment.
Bottom line
The mental health industry is growing as companies rise to meet the demands of a population increasingly challenged with mental health disorders. Investing in therapy stocks can support companies that deliver treatments or develop pharmaceuticals while diversifying your portfolio.
As with all investments, there are risks to investing in mental health stocks, so be sure to carefully research companies and stock trading platforms before you buy in.
Sources
More guides on Finder
-
6 SEC-Approved XRP ETFs You Can Buy Now
Spot XRP ETFs have been approved. Here’s how to invest.
-
How to Buy EquipmentShare.com Stock When It Goes Public
Everything we know about the EquipmentShare.com IPO, plus information on how to buy in.
-
How to Buy BitGo Stock When It Goes Public
Everything we know about the BitGo IPO, plus information on how to buy in.
-
NYSE Holidays 2026: Complete Trading Schedule
What you need to know about NYSE market closures in 2026.
-
How to Buy Sandisk Stock (SNDK)
Steps to add Sandisk stock to your portfolio, with historical pricing, volatility and earnings metrics.
-
Kalshi Review 2026: Comprehensive Event Contract Trading
We review the Kalshi trading platform and explain how investors can use it as a hedge for their investments.
-
Public.com Review 2026: High-Yield Cash, Direct Indexing and More
A beginner-friendly investing platform with fractional shares and no commissions on stocks and ETFs.
-
SoFi Invest® Review 2026 — What’s New, Pros & Cons
SoFi Invest is a zero commissions platform with both active and automated investment accounts.
-
5 Best ETFs for 2026: Top Picks for Strong Returns
Check out the best-performing ETFs so far in 2025.
-
Robinhood Review 2026 — What’s New, Pros & Cons
A deep dive into the highlights and limitations of Robinhood.







